The results of animal experiments show that this product has a certain inhibitory effect on mouse liver cancer solid tumors and mouse sarcoma 180; it can prolong the survival time of mice with lung cancer ascites tumor and Ehrlich ascites tumor.

The results of animal experiments show that this product has a certain inhibitory effect on mouse liver cancer solid tumors and mouse sarcoma 180; it can prolong the survival time of mice with lung cancer ascites tumor and Ehrlich ascites tumor.

The results of animal experiments show that this product has a certain inhibitory effect on mouse liver cancer solid tumors and mouse sarcoma 180; it can prolong the survival time of mice with lung cancer ascites tumor and Ehrlich ascites tumor.

The results of animal experiments show that this product has a certain inhibitory effect on mouse liver cancer solid tumors and mouse sarcoma 180; it can prolong the survival time of mice with lung cancer ascites tumor and Ehrlich ascites tumor.

This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.

Diuretic antihypertensive drugs can increase the antihypertensive effect of reserpine and hydralazine sulfate; they can also reduce their side effects of water and sodium retention.

Vasodilators, which relax arteriolar smooth muscle and reduce peripheral resistance

Reserpine is an adrenergic nerve inhibitor that can prevent the storage of mediators in adrenergic nerve endings and deplete the mediators with pressor effects in the vesicles. Hydralazine sulfate is a vasodilator that can relax arteriolar smooth muscle and reduce peripheral resistance. Hydrochlorothiazide is a diuretic and antihypertensive drug that can increase the antihypertensive effect of reserpine and hydralazine sulfate; it can also reduce their side effects of water and sodium retention. The combined use of the three drugs has a significant synergistic effect, promotes blood pressure reduction, improves efficacy, and thus reduces the dosage and adverse reactions of each drug. Promethazine hydrochloride is an antihistamine that can competitively block H1 receptors to produce antihistamine effects.

Reserpine is an adrenergic nerve inhibitor that can prevent the storage of mediators in adrenergic nerve endings and deplete the mediators with pressor effects in the vesicles. Hydralazine sulfate is a vasodilator that can relax arteriolar smooth muscle and reduce peripheral resistance. Hydrochlorothiazide is a diuretic and antihypertensive drug that can increase the antihypertensive effect of reserpine and hydralazine sulfate; it can also reduce their side effects of water and sodium retention. The combined use of the three drugs has a significant synergistic effect, promotes blood pressure reduction, improves efficacy, and thus reduces the dosage and adverse reactions of each drug. Promethazine hydrochloride is an antihistamine that can competitively block H1 receptors to produce antihistamine effects.

Reserpine is an adrenergic nerve inhibitor that can prevent the storage of mediators in adrenergic nerve endings and deplete the mediators with pressor effects in the vesicles. Hydralazine sulfate is a vasodilator that can relax arteriolar smooth muscle and reduce peripheral resistance. Hydrochlorothiazide is a diuretic and antihypertensive drug that can increase the antihypertensive effect of reserpine and hydralazine sulfate; it can also reduce their side effects of water and sodium retention. The combined use of the three drugs has a significant synergistic effect, promotes blood pressure reduction, improves efficacy, and thus reduces the dosage and adverse reactions of each drug. Promethazine hydrochloride is an antihistamine that can competitively block H1 receptors to produce antihistamine effects.

Adrenergic neurosuppressants can block the storage of mediators in adrenergic nerve endings and deplete the mediators with pressor effects in the vesicles.

Reserpine is an adrenergic nerve inhibitor that can prevent the storage of mediators in adrenergic nerve endings and deplete the mediators with pressor effects in the vesicles. Hydralazine sulfate is a vasodilator that can relax arteriolar smooth muscle and reduce peripheral resistance. Hydrochlorothiazide is a diuretic and antihypertensive drug that can increase the antihypertensive effect of reserpine and hydralazine sulfate; it can also reduce their side effects of water and sodium retention. The combined use of the three drugs has a significant synergistic effect, promotes blood pressure reduction, improves efficacy, and thus reduces the dosage and adverse reactions of each drug. Promethazine hydrochloride is an antihistamine that can competitively block H1 receptors to produce antihistamine effects.

Antihistamines can competitively block H1 receptors and produce antihistamine effects

It has the effect of improving the viscoelasticity of blood rheology, and its anticoagulant effect is equivalent to 1/3 to 1/2 of heparin. It can prevent platelet adhesion to collagen and inhibit platelet aggregation. It has prostaglandin (PGI2)-like effects such as anti-thrombosis, lowering blood viscosity, micro-arteriovenous spasm, and red blood cell and platelet disaggregation. It can significantly lower blood lipids, cholesterol, triglycerides, low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL), increase high-density lipoprotein (HDL), inhibit the occurrence and development of atherosclerotic lesions, dilate peripheral blood vessels, improve microcirculation, inhibit the formation of thrombi in arteries and veins, and has multiple functions such as lowering blood sugar and blood pressure.

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.